EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prevalence of elevated lipoprotein(a) in cardiac rehabilitation patients — results from a large-scale multicentre registry in Germany

Christoph Altmann, Nelu-Adrian Burlacu, Thomas Preuss, Annett Hlousek, Stephan Eddicks, MEDIAN Medical Board Cardiology

Clinical Research in Cardiology · 2026

DOI: 10.1007/s00392-024-02427-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2026. Verfasst von Christoph Altmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department for Cardiology, MEDIAN Rehabilitation-Centre Bad Gottleuba, Königstr. 39, 01816, Bad Gottleuba-Berggießhübel, Germany. chr.h.altmann@web.d…. Hauptthemen laut MEDLINE: Lipoprotein(a), Registries, Aortic Valve Stenosis, Cardiac Rehabilitation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lipoprotein(a) (Lp(a)) is an independent risk factor for myocardial infarction and aortic valve stenosis. European guidelines recommend assessing it at least once in a lifetime, particularly in premature atherosclerotic heart disease.

Methods

A non-interventional registry was conducted at MEDIAN rehabilitation facilities in Germany to assess the frequency of Lp(a) testing in referring acute care hospitals and the prevalence of elevated Lp(a) levels in aortic valve stenosis or premature myocardial infarction. All consecutive patients referred after coronary intervention or aortic valve surgery were included in four cohorts: aortic valve intervention (cohort 1), current/previous myocardial infarction at < 60 years of age (cohorts 2a/2b), and myocardial infarction at ≥ 60 years of age (control).

Results

The analysis included 3393 patient records (cohort 1, n = 1063; cohort 2a, n = 1351; cohort 2b, n = 381; control, n = 598). Lp(a) had been determined at the referring hospital in 0.19% (cohort 1), 4.96% (cohort 2a), 2.36% (cohort 2b), and 2.01% (control) of patients. Lp(a) levels were > 50 mg/dL or > 125 nmol/L in 28.79% (cohort 1), 29.90% (cohort 2a), and 36.48% (cohort 2b; p < 0.001) compared to 24.25% (control). Family history of premature cardiovascular disease was reported in 13.45% (cohort 1), 38.56% (cohort 2a), and 32.81% (cohort 2b) compared to 17.89% (control; p < 0.05 for each comparison).

Conclusions

Lp(a) had been rarely assessed in acute management of aortic valve stenosis or premature myocardial infarction despite expanding scientific evidence and guideline recommendation. Given the above-average incidence of elevated Lp(a) levels, awareness for Lp(a) has to increase substantially to better identify and manage high-risk patients. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)RegistriesAortic Valve StenosisCardiac RehabilitationMyocardial InfarctionHumansGermanyMaleFemaleMiddle AgedPrevalenceAgedBiomarkersRisk Factors

Stichwörter der Autor:innen

Aortic valve stenosisCardiovascular preventionCardiovascular riskLipoprotein(a)Myocardial infarction

Substanzen

Lipoprotein(a)Biomarkers

Autor:innen und Institutionen

  • Department for Cardiology, MEDIAN Rehabilitation-Centre Bad Gottleuba, Königstr. 39, 01816, Bad Gottleuba-Berggießhübel, Germany. chr.h.altmann@web.de.
  • Department for Cardiology, MEDIAN Rehabilitation-Centre Bernkastel-Kues, Bernkastel-Kues, Germany.
  • Department for Research & Innovation, MEDIAN Headquarters, Berlin, Germany.
  • Department for Cardiology, MEDIAN Rehabilitation-Centre Bad Gottleuba, Königstr. 39, 01816, Bad Gottleuba-Berggießhübel, Germany.

Förderung

  • Novartis Pharma

Zitieren

APA

Altmann, C., Burlacu, N. A., Preuss, T., Hlousek, A., Eddicks, S., & MEDIAN Medical Board Cardiology (2026). Prevalence of elevated lipoprotein(a) in cardiac rehabilitation patients — results from a large-scale multicentre registry in Germany. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02427-0

Vancouver

Altmann C, Burlacu NA, Preuss T, Hlousek A, Eddicks S, MEDIAN Medical Board Cardiology. Prevalence of elevated lipoprotein(a) in cardiac rehabilitation patients — results from a large-scale multicentre registry in Germany. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-024-02427-0

BibTeX
@article{Altmann2026,
  author = {Altmann, Christoph and Burlacu, Nelu-Adrian and Preuss, Thomas and Hlousek, Annett and Eddicks, Stephan and MEDIAN Medical Board Cardiology, MEDIAN Medical Board Cardiology},
  title = {Prevalence of elevated lipoprotein(a) in cardiac rehabilitation patients — results from a large-scale multicentre registry in Germany},
  journal = {Clinical Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00392-024-02427-0}
}
Kostenlos starten →